Abstract
Duchenne muscular dystrophy(DMD)is a severe muscular genetic disorder, which is caused by a mutation in the DMD gene encoding the dystrophin protein.The clinical manifestation of DMD is the progressive muscular dystrophy.Myostatin is a negative regulator of skeletal muscle growth and development.In recent years, it has received extensive attention in the treatment of muscle diseases.This review focuses on the structural and activity of myostatin, its regulation of skeletal muscle growth and noval approaches to Myostatin inhibitor in the treatment of DMD. Key words: Duchenne muscular dystrophy; Myostatin; Skeletal muscle; Dystrophin
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
